UCB - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Alcon AG USD 2.78B 90M 2026-06
Almirall EUR 602.71M 55.09M 2026-06
Amarin USD 49.22M 451K 2025-12
argenx SE USD 1.36B 240M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Genmab DKK 1.16B 259M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 12.11M 5.61M 2026-06
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.43B 300M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Orion EUR 521.6M 103.9M 2026-06
Recordati EUR 681.35M 32.07M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
UCB EUR 4.25B 764M 2025-12
Unibail Rodamco EUR 1.49B 77M 2025-12